Short Interest in Evogene Ltd. (NASDAQ:EVGN) Expands By 503.1%

by · The Markets Daily

Evogene Ltd. (NASDAQ:EVGN – Get Free Report) was the target of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 135,100 shares, a growth of 503.1% from the October 31st total of 22,400 shares. Based on an average trading volume of 272,900 shares, the days-to-cover ratio is presently 0.5 days. Approximately 2.6% of the company’s shares are sold short.

Evogene Stock Performance

Shares of EVGN stock opened at $1.69 on Thursday. The company has a market capitalization of $9.06 million, a P/E ratio of -0.37 and a beta of 1.43. The company’s 50 day moving average price is $2.29 and its two-hundred day moving average price is $4.31. Evogene has a 52 week low of $1.44 and a 52 week high of $10.40.

Institutional Trading of Evogene

A hedge fund recently bought a new stake in Evogene stock. Renaissance Investment Group LLC bought a new position in shares of Evogene Ltd. (NASDAQ:EVGN – Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 10,000 shares of the biotechnology company’s stock, valued at approximately $31,000. Institutional investors and hedge funds own 10.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on EVGN. Lake Street Capital reduced their price objective on shares of Evogene from $30.00 to $12.00 and set a “buy” rating on the stock in a research note on Friday, August 23rd. StockNews.com began coverage on shares of Evogene in a research note on Tuesday. They set a “sell” rating on the stock.

Read Our Latest Stock Analysis on Evogene

About Evogene

(Get Free Report)

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.

Featured Stories